Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Carcinoma, Intraductal, Noninfiltrating
  • Receptors, Estrogen
  • Tamoxifen

abstract

  • Seventy-five percent of DCIS lesions were ER-positive. ER staining significantly influenced the likelihood that clinicians would offer tamoxifen to patients with DCIS, but it had no impact on whether patients accepted treatment.

publication date

  • May 15, 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.21873

PubMed ID

  • 16596655

Additional Document Info

start page

  • 2113

end page

  • 8

volume

  • 106

number

  • 10